scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1016269692 |
P356 | DOI | 10.1038/SJ.ONC.1204225 |
P698 | PubMed publication ID | 11313891 |
P2093 | author name string | Lee YJ | |
Lee KH | |||
Kim HR | |||
Kim TH | |||
Billiar TR | |||
Jessup JM | |||
Seol DW | |||
Song YK | |||
P2860 | cites work | Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner | Q22008727 |
An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9 | Q22009407 | ||
Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein | Q22011150 | ||
The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family | Q24315643 | ||
Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 | ||
The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain | Q24320162 | ||
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts | Q28138932 | ||
Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation | Q28199391 | ||
An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 | ||
A novel receptor for Apo2L/TRAIL contains a truncated death domain | Q28255451 | ||
Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes | Q28377454 | ||
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 | Q28609079 | ||
Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy | Q30586812 | ||
Apoptosis control by death and decoy receptors | Q33597389 | ||
Safety and antitumor activity of recombinant soluble Apo2 ligand | Q33855449 | ||
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation | Q34223630 | ||
Biochemistry of Nitric Oxide and Its Redox-Activated Forms | Q35159350 | ||
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors | Q36852093 | ||
p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide | Q40912284 | ||
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
Peroxynitrite-induced apoptosis in HL-60 cells | Q41326019 | ||
Molecular biology of nitric oxide synthases | Q41739514 | ||
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. | Q41747264 | ||
Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells | Q47838631 | ||
Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. | Q52526520 | ||
Ceramide Induces CytochromecRelease from Isolated Mitochondria | Q58287194 | ||
Mitochondrial Nitric-oxide Synthase Stimulation Causes CytochromecRelease from Isolated Mitochondria | Q60532716 | ||
Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2 | Q73329698 | ||
Mitochondria mediate nitric oxide-induced cell death | Q73442980 | ||
How TRAIL kills cancer cells, but not normal cells | Q73632146 | ||
Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition | Q73643152 | ||
Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release | Q73737861 | ||
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand | Q73766150 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nitroprusside | Q420031 |
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 1476-1485 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells | |
P478 | volume | 20 |